In the current month, SION has received 1 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. SION average Analyst price target in the last month is 15.333.

2026-09

2026-08

2026-07

2026-06

2026-05

2026-04

2026-03

2026-02

Strong Buy

Buy

Hold

Strong Sell

Sell

Total

Financial Forecasting

Based on analysts' estimates, SION EPS is projected to reach -0.607 in FY2026Q3, following reported EPS of -0.662 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.

EPS

Revenue

Net Profit

EBIT

Forecast

Actual

FY2025Q4

FY2026Q1

FY2026Q2

FY2026Q3

FY2026Q4

Forecast

-0.54

-0.51

-0.65

-0.61

-0.52

Actual

-0.46

-0.60

-0.66

Surprise

+15.07%

-15.95%

-1.91%

FAQs

How have Sionna Therapeutics IncSION's recent earnings per share performed?



The market expectation was USD -0.66, while Sionna Therapeutics IncSION's earnings per share (EPS) for the previous quarter was USD -0.60. EPS for the next quarter is expected at USD -0.61.

What is the analyst rating for Sionna Therapeutics Inc?



Based on the ratings of Sionna Therapeutics Inc's stock from 11 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.